Page last updated: 2024-08-17

thymidine and chir-265

thymidine has been researched along with chir-265 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aardalen, K; Aziz, N; Gambhir, SS; Hughes, NP; Kaplan, A; Stuart, D; Tseng, JR1

Other Studies

1 other study(ies) available for thymidine and chir-265

ArticleYear
Use of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B-Raf/VEGFR-2 inhibitor.
    Neoplasia (New York, N.Y.), 2011, Volume: 13, Issue:3

    Topics: Animals; Biomarkers, Tumor; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glucose; Humans; Imidazoles; Immunoenzyme Techniques; Leukemia, Myeloid, Acute; Melanoma; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins B-raf; Pyridines; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidine; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays

2011